Cipla Ltd.

Cipla has completed the transfer of Generics Business Undertaking as a going concern on a slump sale basis to Cipla Pharma and Life Sciences, a wholly owned subsidiary of the Company on March 01, 2024.

In November 2023, the company had received approval from board of directors to transfer Generics Business Undertaking. 

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.